“Future-fit.”
“Engagement excellence.”
These buzzwords dominate the pharma conversation. But what do they actually look like in practice? Our report dives beneath the jargon to expose the real changes underway in HCP engagement and capability development.
If your role touches commercialization strategy, learning & development or HCP engagement, this report will challenge your thinking and guide your next move.
We partnered with over 70 commercial, medical, and market access leaders from 20 top pharmaceutical companies – spanning the US, UK, EU, Africa, and APAC – to uncover what’s next for field and remote teams.
Conducted between August – October 2024 by Nazaré’s capability development experts in HCP engagement, this research combines deep-dive interviews and quantitative insights.
Whether you lead a Field Team, oversee training programs, or shape commercial strategies, this report gives you the insight to:
Get ahead of the curve.
Jump to a slide with the slide dots.
Inizio Engage XD earns Highly Commended at the 2026 RoSPA Health and Safety Awards, recognising excellence in global safety culture and risk...
Read more
Inizio launches next-generation patient access Hub Services at Asembia 2026, combining analytics, pharmacy, and expertise to improve access and...
Read more
A cancer diagnosis at 17 changes more than your health—it shapes how you experience care, communication, and life beyond treatment. This reflection...
Read more
Bring Your Child to Work Day 2026 brought energy, creativity, and fresh perspectives to XD, as 43 young minds explored, created, and experienced the..
Read more